Related Experiment Video

Updated: Jul 5, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Do statins slow the progression of aortic valve stenosis?

Christos E Tourmousoglou1, Spiros Lalos, Themistokles Psarros

  • 1Department of Cardiothoracic Surgery, Hippocratio General Hospital, Athens, Greece. christostourmousoglou@hotmail.com <christostourmousoglou@hotmail.com>

Interactive Cardiovascular and Thoracic Surgery
|April 17, 2008
PubMed

Insights

Statins show conflicting results in slowing aortic valve stenosis progression. While some studies suggest a benefit, others show no effect, indicating more research is needed.

Area of Science:

  • Cardiovascular Surgery
  • Pharmacology
  • Clinical Evidence Synthesis

Background:

  • Aortic valve stenosis (AVS) is a progressive condition requiring effective therapeutic strategies.
  • Statins are widely used for lipid management, but their role in AVS progression is debated.

Purpose of the Study:

  • To evaluate the efficacy of statin therapy in slowing the progression of aortic valve stenosis.
  • To synthesize the best available evidence regarding statins and AVS.

Main Methods:

  • A systematic search identified 226 relevant papers, from which twelve were selected as the best evidence.
  • Data from retrospective and prospective studies, including one randomized controlled trial, were analyzed.

Main Results:

  • Conflicting results were observed across the twelve studies.
  • Ten retrospective and one prospective study suggested statins slow hemodynamic progression.
  • One retrospective and one randomized controlled trial found no effect on calcific aortic stenosis progression or regression.

Conclusions:

  • Current evidence on statins for aortic valve stenosis is discrepant, with unclear links to lipid levels or other mechanisms.
  • While not strong enough to alter clinical practice, ongoing large randomized controlled trials (ASTRONOMER, SEAS) will provide crucial future insights.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...